當前位置:杭州昊鑫生物科技股份有限公司>>MCE>>抑制劑>> HY-10108LY294002 抑制劑
產地 | 進口 | 級別 | 其他 |
---|
LY294002 抑制劑
注:本產品僅用于科研,不可用于臨床
生物活性 | LY294002 is a broad-spectrum inhibitor of PI3K with IC50s of 0.5, 0.57, and 0.97 μM for PI3Kα, PI3Kδ and PI3Kβ, respectively[1]. LY294002 also inhibits CK2 with an IC50 of 98 nM[2]. LY294002 is a competitive DNA-PK inhibitor that binds reversibly to the kinase domain of DNA-PK with an IC50 of 1.4?μM. LY294002 is an apoptosis activator[3]. | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
IC50 & Target[1][2][4] |
| ||||||||||||||||||
體外研究 (In Vitro) | LY294002 (0-75 μM; 24 hours and 48 hours) remarkably decreases human nasopharyngeal carcinoma CNE-2Z cells in a dose-dependent fashion[4]. MCE has not independently confirmed the accuracy of these methods. They are for reference only. Cell Proliferation Assay[4]
| ||||||||||||||||||
體內研究 (In Vivo) | LY294002 (10, 25, 50, 75 mg/kg; i.p.; twice weekly; for 4 weeks) significantly reduces mean NPC tumor burden in a dose-dependent manner. LY294002 (10, 25 mg/kg) is less effective in decreasing tumor burden[4]. MCE has not independently confirmed the accuracy of these methods. They are for reference only.
| ||||||||||||||||||
分子量 | 307.34 | ||||||||||||||||||
性狀 | Solid | ||||||||||||||||||
Formula | C19H17NO3 | ||||||||||||||||||
CAS 號 | 154447-36-6 | ||||||||||||||||||
運輸條件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||||
儲存方式 |
| ||||||||||||||||||
溶解性數據 | In Vitro: DMSO : 50 mg/mL (162.69 mM; Need ultrasonic) Ethanol : 50 mg/mL (162.69 mM; Need ultrasonic) 配制儲備液
* 請根據產品在不同溶劑中的溶解度選擇合適的溶劑配制儲備液;一旦配成溶液,請分裝保存,避免反復凍融造成的產品失效。 In Vivo: 請根據您的實驗動物和給藥方式選擇適當的溶解方案。以下溶解方案都請先按照 In Vitro 方式配制澄清的儲備液,再依次添加助溶劑: ——為保證實驗結果的可靠性,澄清的儲備液可以根據儲存條件,適當保存;體內實驗的工作液,建議您現用現配,當天使用; 以下溶劑前顯示的百
|
請輸入賬號
請輸入密碼
以上信息由企業(yè)自行提供,信息內容的真實性、準確性和合法性由相關企業(yè)負責,制藥網對此不承擔任何保證責任。
溫馨提示:為規(guī)避購買風險,建議您在購買產品前務必確認供應商資質及產品質量。